Testosterone for Women: Benefits, Safety, and What to Expect

Testosterone is almost universally discussed as a men's hormone. But women produce testosterone too — from the ovaries and adrenal glands — and they depend on it for energy, libido, cognitive function, muscle maintenance, bone density, and mood regulation. When women's testosterone declines, either gradually through normal aging or abruptly after surgical menopause or certain medications, the consequences are real and frequently dismissed. "It's just hormones" or "this is normal for your age" are the responses too many women receive when they present with symptoms of androgen deficiency. That dismissal doesn't serve them.

Women's Testosterone: What's Normal and What's Deficiency?

Women's testosterone levels are approximately 10–15% of men's — typically ranging from 15–70 ng/dL in premenopausal women, compared to 300–900 ng/dL in men. Despite this lower absolute level, testosterone is just as physiologically essential for women. The reference range for women is less well-standardized than for men, and many labs use assays calibrated for male testosterone levels that lack precision at female concentrations — making accurate testing more challenging and interpretation more nuanced.

Female testosterone declines in a pattern similar to men's but earlier in some cases. By the mid-40s, many women have testosterone levels 50% below their peak. After surgical menopause (oophorectomy), testosterone can drop precipitously — as much as 40–50% immediately — because the ovaries are the primary source of androgen production. Women who've had a hysterectomy with ovarian removal frequently describe a dramatic and sudden change in how they feel that estrogen replacement alone doesn't resolve.

Symptoms of Testosterone Deficiency in Women

The symptom profile of female androgen deficiency overlaps with many other conditions, which contributes to underdiagnosis. Symptoms include:

• Persistent fatigue — not relieved by adequate sleep or standard interventions
• Low libido — reduced sexual desire, arousal difficulty, decreased genital sensation
• Cognitive changes — brain fog, reduced verbal fluency, declining memory
• Muscle weakness and loss — difficulty maintaining muscle mass despite adequate exercise
• Mood changes — irritability, flat affect, reduced motivation and drive
• Bone density loss — testosterone is a key driver of bone mineral density in women
• Reduced sense of well-being — a generalized diminishment that's hard to articulate

These symptoms are often attributed to estrogen deficiency, depression, or simply aging — particularly in perimenopausal women. When estrogen is optimized and symptoms persist, androgen deficiency is the most frequently overlooked remaining cause.

The Clinical Evidence for Testosterone in Women

The strongest evidence for testosterone therapy in women is in the domain of sexual function. The 2019 Global Consensus Position Statement on the Use of Testosterone Therapy for Women — endorsed by 11 international professional societies — concluded that there is strong evidence supporting testosterone therapy for hypoactive sexual desire disorder (HSDD) in postmenopausal women, with a favorable safety profile at physiologic doses.

Beyond sexual function, the evidence base includes:

• Bone density: Multiple studies demonstrate that testosterone therapy improves bone mineral density in postmenopausal women, reducing fracture risk
• Cognitive function: Observational studies and small trials show improvement in verbal memory and cognitive performance; larger trials are ongoing
• Muscle mass: Testosterone has anabolic effects in women at physiologic doses, helping preserve lean mass during menopause
• Mood and well-being: Consistent patient-reported improvement in energy, mood, and overall sense of vitality
• Cardiovascular: Emerging evidence suggests testosterone may have cardioprotective effects in women, including favorable effects on lipid profiles and arterial stiffness

Safe Dosing for Women

The goal of testosterone therapy in women is physiologic replacement — restoring levels to the upper-normal range for premenopausal women, not supraphysiologic elevation. At physiologic doses, the androgenic side effects that concern patients (acne, hair loss, voice changes, clitoral enlargement) are uncommon and generally reversible with dose adjustment.

Common delivery methods for women include:

• Topical creams or gels — low doses applied to the inner arm or thigh; easy to adjust; most commonly prescribed
• Subcutaneous pellets — small pellets inserted under the skin every 3–6 months; provides steady-state delivery without daily application
• Subcutaneous injections — small doses, typically weekly or biweekly; preferred by some patients for precise dosing

No testosterone formulation is FDA-approved specifically for women in the US (the approved formulations are all dosed for men). This means women's testosterone therapy is prescribed off-label — a common practice for many well-established treatments. Your physician should discuss this clearly and document the clinical rationale in your chart.

Pellet Therapy for Women: Steady-State Delivery

Testosterone pellet therapy involves inserting small, rice-sized pellets of crystalline testosterone subcutaneously — typically in the upper buttock under local anesthesia. The pellets dissolve slowly over 3–6 months, delivering consistent testosterone levels without the peaks and troughs associated with topical creams or injections.

Many women prefer pellets because there's no daily application to remember, no transfer risk to partners or children, and levels remain stable throughout the dosing interval rather than rising and falling. The downside is that pellet dosing cannot be immediately adjusted if levels come in too high — unlike creams or injections, which can be modified at the next dose.

Pellet dosing for women is conservative — doses are carefully calibrated to achieve upper-normal premenopausal levels without exceeding the range. We use lab values at the midpoint of the pellet interval to monitor levels and adjust the subsequent dose accordingly.

Monitoring and Safety

Women on testosterone therapy require regular monitoring. We check testosterone levels (total and free), complete blood count, liver function, and lipid panel at baseline and at regular intervals. We also monitor for signs of androgenic excess — which at physiologic doses are uncommon but require prompt dose adjustment if they occur.

The question patients ask most often: is testosterone safe for women with a history of breast cancer? The current evidence does not demonstrate increased breast cancer risk from testosterone therapy at physiologic doses — some data suggests a neutral or even protective effect. However, women with hormone-receptor-positive breast cancer should have a detailed discussion with both their oncologist and prescribing physician before starting any hormonal therapy. This is not a topic for a one-size-fits-all answer.

Revive's Approach to Women's Hormone Optimization

We evaluate testosterone as part of a comprehensive hormonal workup that also includes estradiol, progesterone, DHEA-S, thyroid function, and metabolic markers. Testosterone therapy for women is individualized — the dose, delivery method, and monitoring schedule are built around each patient's symptoms, labs, health history, and preferences. If you've been told your hormones are "fine" but you don't feel fine, a comprehensive evaluation may reveal an androgen component that's been overlooked. Schedule a consultation to discuss your options.